false 0001818644 0001818644 2025-02-20 2025-02-20 0001818644 LIDR:CommonStockParValue0.0001PerShareMember 2025-02-20 2025-02-20 0001818644 LIDR:WarrantsToReceiveOneShareOfCommonStockMember 2025-02-20 2025-02-20 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): February 20, 2025

 

AEYE, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   001-39699   37-1827430
(State or other jurisdiction   (Commission File Number)   (IRS Employer Identification No.)
of incorporation)        

 

4670 Willow Road, Suite 125, Pleasanton, California   94588
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (925) 400-4366

 

 
(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) 
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, par value $0.0001 per share LIDR The Nasdaq Stock Market LLC
Warrants to receive one share of Common Stock LIDRW The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 
 
Item 2.02Results of Operations and Financial Condition.

 

On February 20, 2025, AEye, Inc. (the “Company”) issued a press release announcing its financial results for the quarter and year ended December 31, 2024. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

 

The information provided in Item 2.02 of this Current Report on Form 8-K (including Exhibit 99.1) is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

 

Item 9.01.Financial Statement and Exhibits.

 

(d)Exhibits.

 

Exhibit NumberDescription

 

99.1Press release dated February 20, 2025.

 

104Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

 

 

 

 

 

 

 

 

 

 

 

 

 

 
 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

    AEye, Inc.
     
Dated: February 20, 2025    
    By: /s/ Andrew S. Hughes
      Andrew S. Hughes
      Senior Vice President, General Counsel & Corporate Secretary

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

AEye Reports Fourth Quarter 2024 Results

Apollo launches in US at CES

On-track for Apollo manufacturing ramp with large global Tier 1 partner

Extended cash runway to mid-2026 with new growth capital

 

PLEASANTON, Calif. -- (BUSINESS WIRE) – February 20, 2025 – AEye, Inc. (Nasdaq: LIDR), a global leader in adaptive, high performance lidar solutions, today announced its results for the fourth quarter and year ended December 31, 2024.

Recent Business Highlights

·Launched Apollo in the U.S. with resounding success at CES, showcasing its distinct advantages of behind-the-windshield integration and lower overall system costs
·Began production of first Apollo B samples, reaching a critical milestone for quoting process across multiple sectors
·Beat quarterly cash burn guidance for the fourth consecutive quarter
·Raised additional growth capital to ramp Apollo into high-volume production, strengthening balance sheet and extending cash runway to mid-2026

 

Management Commentary

Matt Fisch, AEye CEO, said, “AEye just closed out a transformational year marked by significant milestones including a new product launch, extended financial runway, increased engagement with OEM customers, and expansion into new markets. Apollo has officially launched in the U.S. and is currently being tested in the field by customers interested in its differentiated capabilities for a range of applications where high visibility is mission critical. Our strategic partnerships in China are also contributing to increased exposure to prospective customers, thanks to our partners’ well-established networks and supply chains in the region.”

“We continue to leverage market enthusiasm for our technology to raise additional growth capital and have extended our cash runway to mid-2026. Heading into the new year, AEye is well-positioned to meet demand from OEMs that view lidar as essential to the future success of their product roadmap.”

Recent Financial Highlights

Cash burn in Q4 2024 was $4.8 million, beating guidance of $4.9 million
GAAP net loss in Q4 2024 was $(8.5) million, or $(0.93) per share, based on 9.1 million weighted average common shares outstanding
Non-GAAP net loss in Q4 2024 was $(6.3) million, or $(0.69) per share, based on 9.1 million weighted average common shares outstanding
Cash, cash equivalents, and marketable securities were $22.3 million as of December 31, 2024
Common shares outstanding of 13.7 million at the end of Q4 2024, compared to 6.3 million common shares outstanding at the end of Q4 2023
 
 

 

Conor Tierney, AEye CFO, said, “Through disciplined cost management, we reduced net cash burn for the seventh consecutive quarter, beating our guidance for both the fourth quarter and full year of 2024.”

“We ended the fourth quarter of 2024 with $22.3 million in cash, cash equivalents, and marketable securities, and raised an additional $12.7 million thus far in 2025, which brings our total potential liquidity to approximately $80 million. Given our strong balance sheet and unique capital-light business model, we have the runway to continue reaching key milestones for Apollo, creating long-term value for shareholders.”

2025 Financial Outlook

AEye expects cash burn for the full year of 2025 to total $25 million, representing a moderate increase compared to cash burn for the full year of 2024 due primarily to investments required to ramp Apollo to high-volume production.

Conference Call and Webcast Details

AEye management will hold a conference call today, February 20, 2025, at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to discuss these results. AEye CEO Matt Fisch and CFO Conor Tierney will host the call, followed by a question-and-answer session.

The webcast and accompanying slides will be accessible via the company’s website at https://investors.aeye.ai/.

Access is also available via:

Conference call: https://aeye.pub/42D3K1p

Webcast: https://aeye.pub/40Dx9FZ

About AEye

AEye’s unique software-defined lidar solution enables advanced driver-assistance, vehicle autonomy, smart infrastructure, and logistics applications that save lives and propel the future of transportation and mobility. AEye’s 4Sight™ Intelligent Sensing Platform, with its adaptive sensor-based operating system, focuses on what matters most: delivering faster, more accurate, and reliable information. AEye’s 4Sight™ products, built on this platform, are ideal for dynamic applications which require precise measurement imaging to ensure safety and performance.

Non-GAAP Financial Measures

The non-GAAP measures provided in this press release should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with generally accepted accounting principles (GAAP) in the United States. A reconciliation between GAAP and non-GAAP financial data is included in the supplemental financial data attached to this press release. Non-GAAP financial measures do not have any standardized meaning and are therefore unlikely to be comparable to similarly titled measures presented by other companies. AEye considers these non-GAAP financial measures to be important because they provide additional insight into the Company’s on-going performance. The Company provides this information to help investors evaluate the results of the Company’s on-going operations and to enable more meaningful and consistent period-to-period comparisons.

 
 

 

Non-GAAP financial measures are presented only as supplemental information to understand the Company’s operating results. The non-GAAP financial measures should not be considered a substitute for financial information presented in accordance with GAAP.

This press release includes non-GAAP financial measures, including:

  Non-GAAP net loss which is defined as GAAP net loss plus stock-based compensation, less expenses related to registration statements and common stock purchase agreements, less change in fair value of convertible note and warrant liabilities, plus realized loss on instrument-specific credit risk, plus one-time termination benefits and other restructuring costs, plus non-routine write-downs of inventory, other current assets and losses on purchase commitments, plus long-lived asset disposals and impairment charges, plus loss (gain) on termination of operating lease, net; and

 

  Adjusted EBITDA, defined as non-GAAP net loss plus depreciation and amortization expense, less interest income and other, less interest expense and other, less benefit (provision) for income tax.

 

Forward-Looking Statements

Certain statements included in this press release that are not historical facts are forward-looking statements within the meaning of the federal securities laws, including the safe harbor provisions under the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements are sometimes accompanied by words such as “believe,” “continue,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “predict,” “plan,” “may,” “should,” “will,” “would,” “potential,” “seem,” “seek,” “outlook,” and similar expressions that predict or indicate future events or trends, or that are not statements of historical matters. Forward-looking statements are predictions, projections, and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Forward looking statements included in this press release include statements about the product manufacturing ramp with a large global Tier 1 partner, the extension of AEye’s cash runway to mid-2026, the potential liquidity available to AEye from its existing financial instruments, and the benefits and advantages of the Company’s Apollo product, among others. These statements are based on various assumptions, whether or not identified in this press release. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as and must not be relied on by an investor as a guarantee, an assurance, a prediction, or a definitive statement of fact or probability. Actual events and circumstances are very difficult or impossible to predict and will differ from the assumptions. Many actual events and circumstances are beyond the control of AEye. Many factors could cause actual future events to differ from the forward-looking statements in this press release, including but not limited to: (i) the risks that the Apollo manufacturing ramp with a large global Tier 1 partner may not occur to the extent anticipated, or at all; (ii) the risks that the new growth capital invested in AEye may not extend the runway to mid-2026 as anticipated due to unexpected expenses, or otherwise; (iii) the risks that Apollo’s behind-the-windshield integration may not have the distinct advantages in the marketplace as anticipated, or at all; (iv) the risks that Apollo may not offer lower overall system costs to the extent anticipated, or at all; (v) the risks that the current field tests being undertaken by customers may not result in further customer interest or sales of product, to the extent anticipated, or at all;

 
 

 

(vi) the risks that the increased exposure in China to prospective customers may not result in further customer interest or sales of our product, to the extent anticipated, or at all; (vii) the risks that the ability to further leverage market enthusiasm for AEye’s technology to raise additional growth capital may not continue to the extent anticipated, or at all; (viii) the risks that AEye’s total potential liquidity may not amount to approximately $80 million as AEye may not be in a position to draw on one or more of the financial instruments upon which the $80 million projection is based, as minimum market conditions must exist in order for AEye to realize all of such potential liquidity; (ix) the risks that the cash burn for the full year of 2025 may exceed $25 million due to unanticipated expenses associated with the investments required to ramp Apollo to high-volume production, or otherwise; (x) the risks that market conditions may create delays in the demand for commercial lidar products beyond AEye’s expectations, if at all; (xi) the risks that lidar adoption occurs slower than anticipated or fails to occur at all; (xii) the risks that AEye’s products may not meet the diverse range of performance and functional requirements of target markets and customers; (xiii) the risks that AEye’s products may not function as anticipated by AEye, or by target markets and customers; (xiv) the risks that AEye may not be in a position to adequately or timely address either the near or long-term opportunities that may or may not exist in the evolving autonomous transportation industry; (xv) the risks that laws and regulations are adopted impacting the use of lidar that AEye is unable to comply with, in whole or in part; (xvi) the risks associated with changes in competitive and regulated industries in which AEye operates, variations in operating performance across competitors, and changes in laws and regulations affecting AEye’s business; (xvii) the risks that AEye is unable to adequately implement its business plans, forecasts, and other expectations, and identify and realize additional opportunities; and (xviii) the risks of economic downturns and a changing regulatory landscape in the highly competitive and evolving industry in which AEye operates. These risks and uncertainties may be amplified by current or future global conflicts and the lingering effects of the COVID-19 pandemic, both of which continue to cause economic uncertainty. The foregoing list of factors is not exhaustive. You should carefully consider the foregoing factors and the other risks and uncertainties described in the “Risk Factors” section of the periodic report that AEye has most recently filed with the U.S. Securities and Exchange Commission, or the SEC, and other documents filed by us or that will be filed by us from time to time with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made.

 

Readers are cautioned not to put undue reliance on forward-looking statements; AEye assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise. AEye gives no assurance that AEye will achieve any of its expectations.

 

 
 

 

AEYE, INC.
Consolidated Balance Sheets
(In thousands)
(Unaudited)
      
   As of December 31,
   2024  2023
ASSETS      
 Current Assets:          
 Cash and cash equivalents  $10,266   $16,932 
 Marketable securities   12,012    19,591 
 Accounts receivable, net   11    131 
 Inventories, net   176    583 
 Prepaid and other current assets   2,706    2,517 
 Total current assets   25,171    39,754 
 Right-of-use assets   652    11,226 
 Property and equipment, net   605    281 
 Restricted cash       2,150 
 Other noncurrent assets   692    906 
 Total assets  $27,120   $54,317 
           
 LIABILITIES AND STOCKHOLDERS’ EQUITY          
 Current Liabilities:          
 Accounts payable  $3,598   $3,442 
 Accrued expenses and other current liabilities   7,709    6,585 
 Total current liabilities   11,307    10,027 
 Operating lease liabilities, noncurrent   479    14,858 
 Convertible note   146     
 Other noncurrent liabilities   64    409 
 Total liabilities   11,996    25,294 
 Stockholders’ Equity:          
 Preferred stock        
 Common stock   1    1 
 Additional paid-in capital   388,213    366,647 
 Accumulated other comprehensive income   5    10 
 Accumulated deficit   (373,095)   (337,635)
 Total stockholders’ equity   15,124    29,023 
 Total liabilities and stockholders’ equity  $27,120   $54,317 

 

 

 

 

 

 
 

 

AEYE, INC.
Consolidated Statements of Operations
(In thousands, except share amounts and per share data)
(Unaudited)
      
   Three months ended December 31,  Twelve months ended December 31,
   2024  2023  2024  2023
Revenue:            
 Prototype sales  $6   $51   $97   $477 
 Development contracts   40    18    105    987 
 Total revenue   46    69    202    1,464 
 Cost of revenue   49    6,668    778    15,319 
 Gross loss   (3)   (6,599)   (576)   (13,855)
 Operating expenses:                    
 Research and development   4,252    5,178    16,389    26,171 
 Sales and marketing   69    1,746    551    12,528 
 General and administrative   4,671    4,955    18,312    25,234 
 Impairment of long-lived assets       9,941        9,988 
 Total operating expenses   8,992    21,820    35,252    73,921 
 Loss from operations   (8,995)   (28,419)   (35,828)   (87,776)
 Other income (expense):                    
Change in fair value of convertible note and warrant liabilities   4    56        (858)
 Interest income and other   143    385    799    1,317 
 Interest expense and other   296    210    (433)   248 
 Total other income (expense), net   443    651    366    707 
 Loss before income tax   (8,552)   (27,768)   (35,462)   (87,069)
 (Benefit) provision for income tax   (4)   14    (2)   57 
 Net loss  $(8,548)  $(27,782)  $(35,460)  $(87,126)
                     
 Per Share Data                    
 Net loss per common share (basic and diluted)  $(0.93)  $(4.44)  $(4.89)  $(14.95)
                     
 Weighted average common shares outstanding (basic and diluted)   9,144,094    6,257,973    7,253,683    5,827,721 

 

 

 

 

 

 

 
 

 

AEYE, INC.
Consolidated Statements of Cash Flows
(In thousands)
(Unaudited)
   
   Twelve months ended December 31,
   2024  2023
Cash flows from operating activities:          
 Net loss  $(35,460)  $(87,126)
 Adjustments to reconcile net loss to net cash used in operating activities:          
 Depreciation and amortization   129    1,547 
 (Gain) loss on sale of property and equipment, net   (12)   59 
Noncash lease expense relating to operating lease right-of-use assets   956    1,406 
 Gain on termination of operating lease, net   (491)   (35)
 Impairment of long-lived assets       9,988 
 Common stock purchase agreement costs   1,124     
 Inventory write-downs, net of scrapped inventory   161    7,712 
 Loss on advances to suppliers       1,385 
 Change in fair value of convertible note and warrant liabilities       858 
 Realized loss on instrument-specific credit risk       46 
 Stock-based compensation   9,047    18,071 
Amortization of premiums and accretion of discounts on marketable securities, net of change in accrued interest   (611)   (211)
 Expected credit losses, net of write-off   35    35 
 Changes in operating assets and liabilities:          
 Accounts receivable, net   85    451 
 Inventories, current and noncurrent, net   245    (2,459)
 Prepaid and other current assets   1,490    2,279 
 Other noncurrent assets   215    284 
 Accounts payable   156    252 
 Accrued expenses and other current liabilities   (2,389)   (3,135)
 Operating lease liabilities   (955)   (1,528)
 Contract liabilities       (987)
 Other noncurrent liabilities   (345)   383 
 Net cash used in operating activities   (26,620)   (50,725)
Cash flows from investing activities:          
 Purchases of property and equipment   (486)   (1,951)
 Proceeds from sale of property and equipment   45    283 
 Purchases of marketable securities   (24,241)   (19,331)
 Proceeds from redemptions and maturities of marketable securities   32,426    76,350 
 Net cash provided by investing activities   7,744    55,351 
Cash flows from financing activities:          
 Proceeds from exercise of stock options   134    455 
 Proceeds from the issuance of convertible note   146     
 Payments for convertible note redemptions       (6,235)
Taxes paid related to the net share settlement of equity awards   (161)   (1,445)
Proceeds from issuance of common stock under the Common Stock Purchase Agreements   11,080    136 
Stock issuance costs related to the Common Stock Purchase Agreements   (1,232)   (3)
Proceeds from issuance of common stock through the Employee Stock Purchase Plan   93    334 
 Net cash provided by (used in) financing activities   10,060    (6,758)
Net decrease in cash, cash equivalents and restricted cash   (8,816)   (2,132)
Cash, cash equivalents and restricted cash at beginning of period   19,082    21,214 
Cash, cash equivalents and restricted cash at end of period  $10,266   $19,082 

  

 
 

AEYE, INC.
Reconciliation of GAAP to Non-GAAP Financial Measures
(In thousands, except share amounts and per share data)
(Unaudited)
      
   Three months ended December 31,  Twelve months ended December 31,
   2024  2023  2024  2023
GAAP net loss  $(8,548)  $(27,782)  $(35,460)  $(87,126)
Non-GAAP adjustments:                    
Stock-based compensation   2,045    3,364    9,047    18,071 
Expenses related to registration statements and common stock purchase agreements   (12)   (50)   1,124    183 
Change in fair value of convertible note and warrant liabilities   (4)   (56)       858 
Realized loss on instrument-specific credit risk               46 
One-time termination benefits and other restructuring costs       1,877        3,347 
Non-routine write-downs of inventory, other current assets and losses on purchase commitments       5,621        8,628 
Long-lived asset disposals and impairment charges       10,185        10,232 
Loss (gain) on termination of operating lease, net   189    (35)   (491)   (35)
Non-GAAP net loss  $(6,330)  $(6,876)  $(25,780)  $(45,796)
Depreciation and amortization expense   49    304    129    1,302 
Interest income and other   (143)   (350)   (799)   (1,282)
Interest expense and other   (284)   (210)   (691)   (294)
(Benefit) provision for income tax   (4)   14    (2)   57 
Adjusted EBITDA  $(6,712)  $(7,118)  $(27,143)  $(46,013)
                     
GAAP net loss per share attributable to common stockholders:                    
Basic and diluted  $(0.93)  $(4.44)  $(4.89)  $(14.95)
Non-GAAP net loss per share attributable to common stockholders:                    
Basic and diluted  $(0.69)  $(1.10)  $(3.55)  $(7.86)
Shares used in computing GAAP net loss per share attributable to common stockholders:                    
Basic and diluted   9,144,094    6,257,793    7,253,683    5,827,721 
Shares used in computing Non-GAAP net loss per share attributable to common stockholders:                    
Basic and diluted   9,144,094    6,257,793    7,253,683    5,827,721 

 

Investor Relations Contacts:

 

Agency Contact

Evan Niu, CFA

Financial Profiles, Inc.

eniu@finprofiles.com

310-622-8243

 

Company Contact

AEye, Inc. Investor Relations

info@aeye.ai

925-400-4366

 

 

 

v3.25.0.1
Cover
Feb. 20, 2025
Document Type 8-K
Amendment Flag false
Document Period End Date Feb. 20, 2025
Entity File Number 001-39699
Entity Registrant Name AEYE, INC.
Entity Central Index Key 0001818644
Entity Tax Identification Number 37-1827430
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 4670 Willow Road
Entity Address, Address Line Two Suite 125
Entity Address, City or Town Pleasanton
Entity Address, State or Province CA
Entity Address, Postal Zip Code 94588
City Area Code (925)
Local Phone Number 400-4366
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company true
Elected Not To Use the Extended Transition Period false
Common Stock, par value $0.0001 per share  
Title of 12(b) Security Common Stock, par value $0.0001 per share
Trading Symbol LIDR
Security Exchange Name NASDAQ
Warrants to receive one share of Common Stock  
Title of 12(b) Security Warrants to receive one share of Common Stock
Trading Symbol LIDRW
Security Exchange Name NASDAQ

AEye (NASDAQ:LIDRW)
Graphique Historique de l'Action
De Jan 2025 à Fév 2025 Plus de graphiques de la Bourse AEye
AEye (NASDAQ:LIDRW)
Graphique Historique de l'Action
De Fév 2024 à Fév 2025 Plus de graphiques de la Bourse AEye